pta20230303046
Managers' transactions announcement according to article 19 MAR

QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR

Venlo (pta046/03.03.2023/22:10 UTC+1) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr. Metin Colpan
2 Reason for the notification
a) Position/status Member of the administrative or supervisory body
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name QIAGEN N.V.
b) LEI 54930036WK3GMCN17Z57
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
  Identification code NL0012169213
b) Nature of the transaction Another
    Release of 9,690 Restricted Stock Units based on grants made on February 28, 2018 and 2020. Exercise Price: $0. Closing Price on February 28, 2023: $45.95. Subsequent to the grant release, receipt of 4,868 Common Shares upon net share settlement wherein a number of Common Share are withheld by the Company to cover related expenses (such as taxes and transaction costs based on share price on vesting date). Grant of 7,917 Restricted Stock Units on February 28, 2023.
    Transaction linked to the exercise of share option programmes
c) Price(s) Volume(s)
  Not Quantifiable Not Quantifiable
d) Aggregated price Aggregated volume
  Not Quantifiable Not Quantifiable
e) Date of the transaction 28.02.2023 UTC+1
f) Place of the transaction Outside a trading venue

(end)

Emitter: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Contact Person: Investor Relations
Phone: +31 7735566 - 00
E-Mail: ir@qiagen.com
Website: www.qiagen.com
ISIN(s): NL0012169213 (Share)
Stock Exchange(s): Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate
Other Stock Exchanges: NYSE, SIX, BX Swiss
|